SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-18-005430
Filing Date
2018-05-02
Accepted
2018-05-02 17:01:06
Documents
1
Period of Report
2017-10-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3101617bruzzese_immudyne.html 3  
1 OWNERSHIP DOCUMENT f3101617bruzzese_immudyne.xml 3 7289
  Complete submission text file 0001213900-18-005430.txt   8687
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Issuer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address
Bruzzese Anthony (Reporting) CIK: 0001739342 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55857 | Film No.: 18800533